A Prospective, Randomized, Controlled, Multicenter Study of Naftopidil for Treatment of Male Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: 75 mg Once Daily in the Evening Compared to 25 mg Thrice Daily
2017 ◽
Vol 24
(7)
◽
pp. 539-547
◽
2014 ◽
Vol 32
(1)
◽
pp. 28
◽